These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8062619)

  • 1. Serum lipoprotein(a) is not increased in NIDDM patients with microalbuminuria.
    Girelli A; Cimino A; Rocca L; Salvi A; Spandrio S; Valentini U; Guistina A
    Diabetes Care; 1994 May; 17(5):456-7. PubMed ID: 8062619
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum LpAI lipoprotein particles in diabetic patients with and without renal lesions of different grades.
    Peynet J; Guillausseau PJ; Legrand A; Altman JJ; Flourie F; Chanson P; Poupon J; N'Guyen M; Warnet A; Lubetzki J
    Diabete Metab; 1993; 19(4):355-60. PubMed ID: 8293861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein(a) is increased in hypertensive NIDDM patients.
    Hancu N; Netea MG; Iancu S
    Diabetes Care; 1995 Jun; 18(6):879-80. PubMed ID: 7555518
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.
    Kodama T; Tomiyama T; Ishizaki T; Baba T
    J Diabetes Complications; 1992; 6(2):70-6. PubMed ID: 1611142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of microalbuminuria and lipid profile among type 2 diabetics].
    Diouf NN; Lo G; Sow-Ndoye A; Djité M; Tine JA; Diatta A
    Rev Med Brux; 2015; 36(1):10-3. PubMed ID: 25856966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein(a) in patients with diabetes mellitus.
    Heller FR; Jamart J; Honore P; Derue G; Novik V; Galanti L; Parfonry A; Hondekijn JC; Buysschaert M
    Diabetes Care; 1993 May; 16(5):819-23. PubMed ID: 8495624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria.
    Seghieri G; Alviggi L; Caselli P; De Giorgio LA; Breschi C; Gironi A; Niccolai M; Bartolomei GC
    Diabet Med; 1990 Nov; 7(9):810-4. PubMed ID: 2148134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
    Alagözlü H; Gültekin F; Candan F
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) and vascular disease in diabetic patients.
    James RW; Boemi M; Sirolla C; Amadio L; Fumelli P; Pometta D
    Diabetologia; 1995 Jun; 38(6):711-4. PubMed ID: 7672494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein (a) concentration in diabetes mellitus.
    Vendrell J; Gutiérrez C; Pastor R; Richart C
    Diabetologia; 1993 Sep; 36(9):881-2. PubMed ID: 8405763
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.
    Pan J; Gao F; Bao Y; Zhang L; Tu Y; Jia W
    J Clin Lipidol; 2012; 6(4):382-7. PubMed ID: 22836076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study.
    Smulders YM; Rakic M; Stehouwer CD; Weijers RN; Slaats EH; Silberbusch J
    Diabetes Care; 1997 Jun; 20(6):999-1005. PubMed ID: 9167114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological variation of lipoprotein(a) in a diabetic population. Analysis of the causes and clinical implications.
    Hernández C; Francisco G; Chacón P; Mesa J; Simó R
    Clin Chem Lab Med; 2003 Aug; 41(8):1075-80. PubMed ID: 12964817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation.
    Moro E; Zambon C; Pianetti S; Cazzolato G; Pais M; Bittolo Bon G
    Acta Diabetol; 1998 Oct; 35(3):161-4. PubMed ID: 9840454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
    Islam N; Kazmi F; Chusney GD; Mattock MB; Zaini A; Pickup JC
    Diabetes Care; 1998 Mar; 21(3):385-8. PubMed ID: 9540020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.